UV-Spectropectrophotometry for Determination of Diazepam by Comparative Estimation of Methods of Calibration Curve and Reference Standard

 

Dobrina Tsvetkova1*, Stefka Ivanova2, Maria Chaneva3

1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medical University-Pleven, Sofia 1000, Bulgaria.

2Bulgarian Scientific Society of Pharmacy, Bulgaria.

3Clinic of Inrermnal Medicine, UMBALSM ”N. I. Pirogov” – Sofia, Bulgaria.

 

*Email: [email protected]


ABSTRACT

The objective of the current work was to compare the methods of the calibration curve (MCC) and the external reference standard (MRS) for estimating the analytical parameters accuracy and precision in order to validate the UV-spectrophotometric method for the determination of diazepam at λmax = 328 nm in 95% ethanol. The fact that the detected absorbance at λmax = 328 nm, a particular wavelength for diazepam, could not be found in the UV spectra of the blank solution was provided as evidence of selectivity. Analysis using linear regression was performed on the experimental findings: y = 14387.x +0.05. An analysis of linearity was conducted by measuring the linear regression coefficient: R2 > 0.998. LOD = 1.84.10–5 g/ml; LOQ = 1.04.10–5 g/ml. Accuracy was reflected and determined by recovery degree R [%] ± RSD [%] as per ICH guidelines: MCC: 100.49 % ± 1.35 %; MRS: 105.56 % ± 1.37 %. The fact that SD and RSD were less than 1.5 confirmed that the findings and actual values were in agreement. From the precision assessment, all values for the content of Diazepam, obtained both by MRS and MCC at the confidence possibility P = 98%, suit the relevant confidence interval: MCC: 4.88 mg ¸ 4.96 mg; MRS: 5.12 mg ¸ 5.20 mg. Through the use of all of these data, it was demonstrated that the validated approach was reliable and accurate for determining the dose of Diazepam in medication formulations.

Key words: Diazepam, Spectrophotometry, Validation, Accuracy, Precision


INTRODUCTION

Diazepam (7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one (Figure 1) is applied commonly for therapy of features associated with alcohol, opiate, and benzodiazepine withdrawal, anxiety and trouble sleeping [1]. The drug is used as miorelaxant [2] for muscle spasms and induced by stroke paresis [3]. Diazepam posesses effect on the growth of Chrysomya albiceps in rabbit carcass [4]. Diazepam is applied as an anesthetic for preoperative premedication before endoscopic or surgical procedures like open-heart surgery [5] or aortic valve implantation [6].

In European Pharmacopoeia [7] and British Pharmacopoeia [8] for the determination of Diazepam substance is applied acid-base neutralization non-water method in the medium of acetic anhydride and titration with 0.1 M perchloric acid by using indicator Nile blue [7] or potentiometrically [8] with Diazepam ion-selective electrode [9]. For simultaneous potentiometric quantification of Diazepam, Bromazepam, and Clonazepam has been described as the method with solid contact ion-selective electrodes [10]. Electrochemical assay of Diazepam in pharmaceutical products by polarography has been reported [11].

The advantages of the titrimetric method are the short time of analysis, quick and easy performance, cost-effectivity, and simple instrumentation [12]. The disadvantage of titrimetric methods is the lack of selectivity for the analysis of combinations in comparison with the separation techniques: gas chromatography, HPLC, and capillary electrophoresis, which offer significant advantages, such as high separation efficiency, fast analysis, and small sample volumes [13].

Diazepam dose estimation in tablet form using the RP-HPLC technique has been introduced [3]. For the simultaneous measurement of Diazepam and Otilonium bromide in tablets, reversed-phase liquid chromatography and capillary electrophoresis have been devised [14, 15].

Fluorimetry has been applied for the quantification of Diazepam in tablets and injections [16] and of other drugs [17]. Spectrophotometric and fluorimetric methods for the assay of Diazepam, Bromazepam, and Clonazepam in pharmaceutical and urine samples have been used [18].

The drawback of HPLC is that it requires a trained technician for monitoring. In comparison with HPLC, the advantages of UV-spectrophotometric methods are simplicity of procedures and economy [19].

The following spectrophotometric techniques for analyzing Diazepam have been published:

  1. first-order derivative UV-spectrophotometry for determination of Diazepam alone [20] and for simultaneous quantification in combination with Diazepam and Otilonium bromide [21],
  2. second-order-derivative spectrophotometry for analysis of mixtures of 1,4-benzodiapines [22],
  3. ratio-spectra derivative spectrophotometry for simultaneous assay of Diazepam and Otilonium bromide [23],
  4. visible spectrophotometry for Diazepam in pure form, tablets, and ampoules after the interaction with picric acid at λ = 475 nm and with 3,5-dinitrobenzoic acid and 2,4-dinitrobenzoic acid at λ = 500 nm [24].

Mass spectrometry is also used for drug analysis [25]. Derivative spectrophotometry has the drawback of being sensitive to adjustments in the settings of the device. Particularly in the zero-crossing approach, which lacks repeatability due to inaccuracies in the registration of the spectrum, small variations in the wavelength setting have a significant impact on the outcome [26]. Chemometric assisted spectrophotometric method is applied for the simultaneous evaluation of drugs, such as of Amlodipine Besylate and Candesartan Cilexeti [27]. Contrary to the UV-derivative approach, the standard UV method has lower sensitivity to changes in the apparatus settings and is one of the most widely used methods for pharmaceutical analysis because it is quick, easy, specific, accurate, and speedy [19].

Due to the content chemical structure of chromophore groups, Diazepam is developed UV-spectrophotometric methods for direct determination in the ultraviolet region without the need for a derivatization reaction. UV-spectrophotometric method for analysis of Diazepam substance in solvent mixture methanol: distilled water = 1: 1 at λ = 231 nm has been described [26]. UV-spectrophotometric methods for quantification of Diazepam and Sodium benzoate in dosage drug forms at λ = 306 nm [28] and for simultaneous assay of Diazepam, Caffeine, and Phenylpropanolamine hydrochloride in tablets have been developed [29].

Following British Pharmacopoeia the determination of Diazepam in tablets is spectrophotometrically in UV-area in 0.5 % methanolic sulphuric acid a by method of specific absorbance: A(1%, 1 cm) = 450 at λ = 284 nm [7].

By estimating analytical characteristics such as selectivity, linearity, LOD, LOQ, accuracy, and precision, the current study aimed to validate and compare traditional UV-spectrophotometric techniques of calibration curves and methods of external standards for the measurement of Diazepam in ethanol.

MATERIALS AND METHODS

Materials

  1. Reference standard (RS): Diazepam.
  2. Purity-graded chemicals for analytical use: SZBD 0500 V UN 1170, Sigma Aldrich, 95% ethanol.

 

Method. UV-Spectrophotometry

 

  1. Equipment.

UV-VIS diode array spectrophotometer (Hullett Packard N: 8452 A).

 

  1. Preparation of blank solution for estimation of an analytical parameter selectivity.

To estimate the analytical parameter selectivity, a blank solution in 95% ethanol was made. Diazepam-free supplement starch, which is utilized in tablet manufacturing, was added to blank solutions. A volumetric flask was used to dissolve 0.05 g of supplement starch that had been precisely weighed in 95% ethanol to a volume of 25.0 ml, and a portion of the solution equal to 1.0 ml was divided into 10.0 ml and then diluted again in 95% ethanol. 95% ethanol was applied as a blank solution. The data for the absorbance were measured at λ = 328 nm.

 

  1. Preparation of solutions of reference standard Diazepam in 95% ethanol for estimation of analytical parameter linearity.

95% ethanol was used to dissolve a precisely measured amount of the reference standard Diazepam (25 mg, 37.5 mg, 50 mg, 75 mg, 100 mg, 125 mg, and 175 mg), and the same solvent was then used to dilute the solution to 250.0 ml in volumetric flasks. Aliquot portions of 10.0 ml of the obtained solutions were diluted in 95% ethanol to 100.0 ml in volumetric flasks, resulting in solutions with equivalent concentrations of diazepam: 1.10–5 g/ml, 1.5.10–5 g/ml, 2.10–5 g/ml, 3.10–5 g/ml, 4.10–5 g/ml, 5.10–5 g/ml and 7.10–5 g/ml. All solutions were analyzed at λ = 328 nm against 95% ethanol and the absorbances were measured.

 

  1. Preparation of model mixture with Diazepam for validation of the UV-method for analytical parameters accuracy and precision (repeatability). 

By adding an active ingredient, Diazepam, equal to 100% (5 mg) of the theoretical concentration of Diazepam in tablets (5 mg), a model combination was created from the supplement in tablet form (starch). The model combination weighed 0.05 g on average. The model mixture amount, which is equal to 5 mg of benzodiazepine, was precisely measured to create six identical, homogeneous samples. All samples were dissolved in 95% ethanol and were diluted with 95% ethanol to 25.0 ml in volumetric flasks. The produced solutions were diluted in volumetric flasks with aliquots of 1.0 ml each in 95% ethanol to 10.0 ml. As the blank solution, 95% ethanol was used to measure the absorbances of the produced solutions at λ = 328 nm.

 

  1. Preparation of reference solution of Diazepam for the method of an external standard.

In volumetric flasks, 95% ethanol was used to dilute a precisely measured quantity of 5 mg of the reference standard benzodiazepine to 25.0 ml. Diazepam solutions with various concentrations were created by diluting aliquot portions of the resultant solution, which included 1.0 ml, in 95% ethanol to 10.0 ml in a volumetric flask: 2.10–5 g/ml. The absorbance of the final solution was detected at λ = 328 nm applying 95% ethanol as compensation.

 

  1. Root limit mean square error method (RMSE) for the determination of limit of detection (LOD) and limit of quantitation (LOQ).

 

 

The examination of solutions with low concentrations was used to create calibration curves. After the data underwent linear regression analysis, the linear correlation coefficients (R2) were discovered. The regression equation: y = a.x + b was applied for obtaining the data for the predictable absorbance (Ap); the error E = |Ap - A|; E2 = [|Ap - A|]2, E1= ; RMSE = , LOD = 3.RMSE/а, LOQ = 10.RMSE/а [30].

 

RESULTS AND DISCUSSION

Validation of UV-spectrophotometric method [31-34]

  1. Estimation of analytical parameter selectivity

                When a component that could be present in the sample matrix is present, the analyte is quantitatively detected by selectivity [35, 36]. Selectivity was demonstrated by the absence of measurable absorption at the targeted wavelengths in the UV spectra of blank solutions.

 

  1. Investigation of analytical parameter linearity, accuracy and precision.

Application of the method of linear regression analysis

Linearity is the portion of a detector-derived signal that continues to exhibit a linear relationship with the analyte's concentration [31-35].

A series of solutions with increasing concentrations (1.10-5 g/ml ÷ 7.10-5 g/ml) were created in order to investigate the linearity of analytical parameters from the reference standard Diazepam. For the investigation of analytical parameter accuracy and repeatability 6 mixtures containing Diazepam were prepared. The absorbances (A) at wavelength λ = 328 nm were measured and UV-spectra were detected and were demonstated on Figure 1.

 

Linearity

Accuracy and precision

a)

b)

Figure 1. UV-spectra for standard solutions of Diazepam.

 

Table 1 provides an overview of the experimental findings for the observed absorbances of a number of solutions with escalating Diazepam doses.

 

 

 

 

Table 1. Concentrations and absorbances for reference standards of Diazepam in 95% ethanol for estimation of analytical parameter linearity.

N:

C [g/ml]

A

1.

1.105

0.18515

2.

1.5.10–5

0,27440

3.

2.10–5

0.32350

4.

3.10–5

0.49339

5.

4.10–5

0.61980

6.

5.10–5

0.78979

7.

7.10–5

1.0435

               

The obtained experimental results for absorbances of reference standards of Diazepam were used to linear regression analysis. The regression equation's parameters, which showed a linear connection between absorbances and concentrations at the relevant concentration intervals, were given in Table 2.

 

Table 2. Parameters of the regression equation for Diazepam.

N:

Parameter

Result

1.

The linear interval [g/ml]

1.105 ÷ 7.105

2.

Regression equation

y = 14387.49. x + 0.05

3.

Slope (a)

14387.49

4.

Standard slope error

286.9014

5.

Inrersept  (b)

0.049782

6.

Standard intercept error

0.011178

7.

Correlation coefficient (R2)

0.9980

Figure 2 depicts the calibration curve, which demonstrates the linear connection between A and concentration C [g/ml]. Linear regression coefficients serve as a measure of linearity: R2 > 0.9980.

Figure 2. Calibration curve for linearity for Diazepam.

 

  1. Estimation of analytical parameters limit of detection (LOD) and limit of quantitation (LOQ).

Table 3 includes the findings from the examination of standard solutions containing progressively higher concentrations of Diazepam  to investigate LOD and LOQ: C [g/ml] –  concentration, A – measured absorbance, Ap – calculated by calibration curve absorbance, Е = |Ap A|, Е2 = [|Ap A|]2, RMSE = , LOD = 3.RMSE/а, LOQ = 10.RMSE/а. LOD and LOQ are based on the regression equation: y = 14387.49. x + 0.05 by application of RMSE-method [30].

 

Table 3. RMSE method for LOD and LOQ for Diazepam in 95% ethanol.

N:

C [g/ml]

A

Ap

E = |Ap A|

Е2 = [|Ap A|]2

1.

1.105

0.18515

0.19387

0,00872

0.00008

2.

1.5.10–5

0,27440

0.26581

0,00859

0.00007

3.

2.10–5

0.32350

0.33775

0,01425

0.00020

4.

3.10–5

0.49339

0.48162

0,01177

0.00014

5.

4.10–5

0.61980

0.62550

0,00570

0.00003

6.

5.10–5

0.78979

0.76937

0,02042

0.00042

7.

7.10–5

1.04350

1.05712

0,01362

0.00019

E1= = 0.000226

RMSE= = 0.015

LOD = (3.0.015)/14387.49 = 3.13.10-6 g/ml

LOQ = (10.0.015)/14387.49 = 1.04.10-5 g/ml

 

  1. Estimation of analytical parameters accuracy and precision for Diazepam

Table 4 are presented values for: 1) included content of Diazepam; 2) weighed quantity of Diazepam for analysis; 3) absorbances: A, ASt  = 0.32350. 

Table 4. Added and content aud absorbances for mixtures of Diazepam.

N:

Added  content [mg]

Weight content  [g]

Absorbance  A

1.

4.84

0.0484

0.32530

2.

4.86

0.0486

0.32675

3.

4.88

0.0488

0.32687

4

4.91

0.0491

0.32707

5.

4.92

0.0492

0.32709

6.

4.94

0.0494

0.32747

X

 

 

0.32676

SD

 

 

0.0008

RSD [%]

 

 

0.24

Table 5. Obtained quantity (C), recovery (R), and Schöveneou¢s criterion (U) for C –estimation by methods of the calibration curve and of external standards.

The data for Chauvenet's criteria are lower for all of the observed experimental findings than the highest permitted standard requirement: U < 1.73 (n = 6) is used to determine if findings with sharp discrepancies should be eliminated.

 

Accuracy

A sample standard deviation (SD) is determined for the estimation of accuracy and precision by using Bessel's adjustment.

Accuracy is the level of agreement between the mean result of the repeated measurements and the real values. By carrying out the recovery for 6 samples at a level equal to 100% of the nominal concentration, the accuracy of the procedure was assessed. R [%] ± RSD [%] was used as a measure of accuracy in accordance with ICH recommendations [31-34]: MCC: 100.49 % ± 1.35 %; MRS: 105.56 % ± 1.37 %. Results indicate that all data for degree of recovery fit respective confidence intervals at the specified confidence level P = 98%: MCC:  98.60 % ¸ 102.38 %; MRS: 103.57 % ¸ 107.55 %. SD and RSD were less than 1.5, demonstrating agreement between the findings and real values.

 

Precision (repeatability)

The uncertainty of the outcome, which is calculated by the SD, RSD, and CI [30-36], is employed for the estimate of an analytical parameter with accuracy (repeatability). By scanning samples of Diazepam (n = 6) repeatedly, repeatability was achieved. It is clear from the assessment of precision that all values for the content ofDiazepam, obtained by MES and MCC at the confidence level P = 98%, are consistent with the applicable confidence interval: MCC: 4.88 mg ¸ 4.96 mg; MRS: 5.12 mg ¸ 5.20 mg. Due to the close proximity of the findings to the average value and the corresponding small confidence interval, all values for SD are less than SD = 1.5, indicating good accuracy.

CONCLUSION

The current UV-spectrophotometric technique was validated in accordance with the ICH criteria for the analytical parameters of selectivity, linearity, LOD, LOQ, accuracy, and precision for the measurement of diazepam in 95% ethanol using the method of the calibration curve and the methodology of the external standard. The consistency of the results for repeatability and accuracy within the appropriate confidence intervals demonstrated that the validated technique was determined to be precise and accurate for use in determining the amount of diazepam in the dose medication formulation.

ACKNOWLEDGMENTS : None

CONFLICT OF INTEREST : None

FINANCIAL SUPPORT : None

ETHICS STATEMENT : None

References

1.       Calcaterra NE, Barrow JC. Classics in chemical neuroscience: Diazepam (Valium). ACS Chem Neurosci. 2014;5(4):253-60. doi:10.1021/cn5000056

2.       Marinova P, Temelkov A, Abedinov F. Influence of hypnotics and muscle relaxants on EEG and index values from EEG analysis. Anesthesiol Int Ther. 2017;46(4):16-8.

3.       Sruthi A, Tejaswi P, Thanuja N, Kumar SD, Sagar VP. Simple RP-HPLC method for estimation of Diazepam in tablet dosage form. J Pharm Res. 2013;6(1):140-4. doi:10.1016/j.jopr.2012.11.029

4.       Al-Shareef LO, Alazwari OM, Al-Ghamdi SS. Effect of Diazepam on the growth of Chrysomya albiceps (Wiedemann 1819) (Diptera: Calliphoridae) in rabbit carcass. Entomol Appl Sci Lett. 2021;8(2):100-8. doi:10.51847/I7lrmSia0M

5.       Karahalil B, Yağar S, Bahadir G, Durak P, Sardaş S. Diazepam and Propofol used as anesthetics during open-heart surgery do not cause chromosomal aberrations in peripheral blood lymphocytes. Mutat Res Genet Toxicol Environ Mutagen. 2005;581(1-2):181-6. doi:10.1016/j.mrgentox.2004.10.021

6.       Tsaryanski G, Markovski A, Abedinov F, Cholakov V, Dimitrova V, Petkov D, et al. Anesthesiological resuscitation features of transcatheter aortic valve implantation. Results in 17 patients. Anesthesiol Int Ther. 2011;40(2):8-12.

7.       British Pharmacopoeia 2000, 3rd edition. England: Her Majesty Stationery office; 2000. p.523.

8.       European Pharmacopeia, 6th ed., Council of Europe, Strasbourg; 2008.

9.       Nie L, Liu D, Yao S. Potentiometric determination of Diazepam with a Diazepam ion-selective electrode. J Pharm Biomed Anal. 1990;8(4):379-83. doi:10.1016/0731-7085(90)80053-r

10.    Salem A, Barsoum B, Izake E. Potentiometric determination of Diazepam, Bromazepam and Clonazepam using solid contact ion-selective electrodes. Anal Chim Acta. 2003;498(1-2):79-91. doi:10.1016/j.aca.2003.08.070

11.    Garcia MG, Garcia A, Gonzalez I. Extraction and electrochemical quantification of the active ingredients (Diazepam) in pharmaceutical products. Talanta. 1993;40(12):1775-9. doi:10.1016/0039-9140(93)80096-a

12.    Bonfilio R, De Araujo MB, Salgado HRN. Recent applications of analytical techniques for quantitative pharmaceutical analysis: a review. WSEAS Transact Biol Biomed. 2010;4(7):316-38. Available from: http://hdl.handle.net/11449/71921

13.    Bonfilio R, Cazedey E, Araújo M, Nunes-Salgado H. Analytical validation of quantitative High-Performance Liquid Chromatographic methods in pharmaceutical analysis: a practical approach. Crit Rev Anal Chem. 2012;42(1):87-100. doi:10.1080/10408347.2012.630926

14.    Furlanetto S, Orlandini S, Massolini G, Faucci MT, La Porta E, Pinzauti S. Optimisation and validation of a capillary electrophoresis method for the simultaneous determination of Diazepam and Otilonium bromide. Analyst. 2001;126(10):1700-6. doi:10.1039/b103091b

15.    Aurora-Prado MS, Steppe M, Tavares MFM, Kedor-Hackmann ERM, Santoro MIRM. Comparison of capillary electrophoresis and reversed-phase liquid chromatography methodologies for determination of Diazepam in pharmaceutical tablets. J Pharm Biomed Anal. 2005;37(2):273-9. doi:10.1016/j.jpba.2004.10.026

16.    Ouyang Y, Cai W, Xue S, Xu J, Guo X. Study of the photochemical fluorimetric method. III. Determination of Diazepam in tablets and injections. Fenx Huaxue. 1992;20(48):116.

17.    Parmar K, Desai A. Preparation and optimization of quick/slow-release bilayered tablets of Prazosin HCl using DoE and PCA. Pharmacophore. 2022;13(2):80-7. doi:10.51847/7Ap1qgnqwF

18.    Salem AA, Barsoum BN, Izake EL Spectrophotometric and fluorimetric determination of Diazepam, Bromazepam and Clonazepam in pharmaceutical and urine samples. Spectrochim Acta A Mole Biomol Spectrosc. 2004;60(4):771-80. doi:10.1016/s1386-1425(03)00300-7

19.    Kus S, Marczenko Z, Obarski N. Derivative UV-VIS spectrophotometry in analytical chemistry. Chern Anal Warsaw. 1996;41(1):899-927.

20.    Dastidar DG, Biswanath SA. Comparative study of UV-spectrophotometry and first-order derivative UV-spectrophotometry methods for the estimation of Diazepam in presence of Tween-20 and propyleneglycol. AAPS Pharm Sci Tech. 2009;10(4):1396. doi:10.1208/s12249-009-9343-x

21.    Mannucci C, Bertini J, Cocchini A, Perico A, Salvagnini F, Triolo A. Simultaneous determination of Otilonium bromide and Diazepam by first derivative spectroscopy. J Pharmaceut Sci. 1992:81(12):1175-7. doi:10.1002/jps.2600811209

22.    Corti P, Aprea C, Corbini G, Dreassi E, Celesti, L. Derivative resolution in the spectrophotometrric assay of pharmaceuticals. IV. Analysis of mixtures of 1,4-benzodiapine compounds. Pharm Acta Helv. 1991;66:50-5.

23.    Morelli B. Determination of Diazepam and Otilonium bromide in pharmaceuticals by ratio-spectra derivative spectrophotometry. Fresenius’ J Anal Chem. 1997;357(8):1179-84. doi:10.1007/s002160050327

24.    El-Hawary WF, Issa YM, Talat A. Spectrophotometric determination of Diazepam in pure form, tablets and ampoules. Int J Biomed Sci. 2007;3(1):50-5.

25.    Udristioiu A, Giubelan A, Nica-Badea D. Determination of trace elements in hair analysis using ICP Mass spectrometry. Pharmacophore. 2021;12(3):54-9. doi:10.51847/Ft7qx3VOb5

26.    Chakraborty S, Sharmin S, Rony SR, Ahmad SAI, Sohrab MDH. Stability-indicating UV/Vis spectrophotometric method for Diazepam, development and validation. Indian J Pharma Sci. 2018;80(2):366-73. doi:10.4172/pharmaceutical-sciences.1000366

27.    Hinge MA, Patel D, Shah M. Simultaneous evaluation of Amlodipine Besylate and Candesartan Cilexetil by applying chemometric assisted spectrophotometric method. Pharmacophore. 2022;13(1):1-9. doi:10.51847/w6HZZFmInJ

28.    Jain NS, Maheshwari RK, Nema RK, Singhvi I. Development and validation of simple UV-spectrophotometric method of quantiztion of Diazepam in bulk drug and solid dosage formulation using mixed solvency concept. Int J Curr Pharm Res. 2017;9(6):15-7. doi:10.22159/ijcpr.2017v9i6.23421

29.    Ferreyra CF, Ortiz CS. Simultaneous spectrophotometric determination of phenylpropanolamine hydrochloride, caffeine and diazepam in tablets. J Pharmaceut Biomel Anal. 2002;29(5):811-8. doi:1016/s0731-7085(02)00130-9

30.    Shrivastava A, Gupta VB. Methods for the determination of limit of detection and limit of quantitation of the analytical methods. Chron Young Sci. 2011;2(1):21-5. doi:10.4103/2229-5186.79345

31.    International Conference on Harmonization Topic Q 2 (R1). Validation of Analytical Procedures: Text and Methodology. CPMP/ICH/381/95) European Medicines Agency. 1995.

32.    International Conference on Harmonization of Technical Requirement for Registration of Pharmaceuticals for Human use, ICH harmonized tripartite Guideline, Validation of Analytical procedures Text and methodology Q2 (R1). 2005.

33.    Gamil AM. Validation as applied for pharmaceutical processes. J Adv Pharm Educ Res. 2015;5(2):77-86.

34.    Ermer J, Ploss HJ. Validation in pharmaceutical analysis – Part II: central importance of precision to establish acceptance criteria and for verifying and improving the quality of analytical data. J Pharm Biomed Anal. 2005;37(5):859-70. doi:10.1016/j.jpba.2004.06.018

35.    Pedro A. Key aspects of analytical method validation and linearity evaluation. J Chromatogr B Anal Technol Biomed Life Sci. 2009;877(23):2224-34. doi:10.1016/j.jchromb.2008.09.030

36.    Shrivastava S, Deshpande P, Daharwal S. Key aspects of analytical method development and validation. J Ravishankar Univ (PART-B). 2019;31(1):32-9. doi:10.52228/jrub.2018-31-1-6